Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer.

Armstrong, A J

Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer. [electronic resource] - Prostate cancer and prostatic diseases Jun 2010 - 108-16 p. digital

Publication Type: Journal Article; Review

1476-5608

10.1038/pcan.2009.62 doi


Androgen Antagonists--therapeutic use
Antineoplastic Agents--administration & dosage
Clinical Trials as Topic
Docetaxel
Drug Administration Schedule
Humans
Male
Neoplasm Metastasis--prevention & control
Orchiectomy
Prednisone--therapeutic use
Prognosis
Prostatic Neoplasms--drug therapy
Substance Withdrawal Syndrome
Taxoids--administration & dosage
Treatment Outcome